pharmaceutical-investing KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
pharmaceutical-investing KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD